Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome

OBJECTIVE—To determine whether, in accordance with observations in mouse models, high concentrations of the lipoprotein lipase inhibitors apolipoprotein (Apo) CI and ApoCIII are associated with increased triglyceride concentrations and decreased fat mass in men with the metabolic syndrome. RESEARCH...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Ham, Rachel L.M., Dehnavi, Reza Alizadeh, Berbée, Jimmy F.P., Putter, Hein, de Roos, Albert, Romijn, Johannes A., Rensen, Patrick C.N., Tamsma, Jouke T.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606811/
https://www.ncbi.nlm.nih.gov/pubmed/18835943
http://dx.doi.org/10.2337/dc08-1330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606811/
https://www.ncbi.nlm.nih.gov/pubmed/18835943
http://dx.doi.org/10.2337/dc08-1330

Ejemplares similares